glp 1 stop taking New research is a closer look at what can happen a year or more after people taking GLP-1 medications 6 Ways to Safely Stop

When it comes to glowing skin, we all have trouble of finding the perfect product for our skin type, We may end up with multiple chemical products that don't even give us pure satisfaction, but damage our skin entirely

Blood tests may help rule out other conditions

Check with your carrier for your specific plan

Regulatory and Ethical Considerations Current Approval Status (2026) As of 2026, neither cagrilintide nor retatrutide has received FDA approval for obesity treatment or metabolic applications

The FDA announced the action on April 15, 2026 (Federal Register notice April 16), and the peptides come off the Category 2 list effective April 23, 2026